Australian Association Alleges Anti-Competitive Adalimumab Antics From AbbVie
Biosimilars Body Points To Letters And Materials From Humira Originator
Executive Summary
AbbVie is spreading confusion among Australian doctors and patients with anti-competitive materials designed to fend off biosimilar adalimumab competition to Humira, according to a local biosimilars industry association.